KINTARA THERAPEUTICS INC (KTRA)
US49720K2006 - Common Stock
| TTM (2023-12-31) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -10.59M | -14.65M | -22.66M | -38.30M | -9.13M | |||
| Depreciation Amortization | 60.00K | 60.00K | 60.00K | 30.00K | 10.00K | |||
| Change In Working Capital | 368.00K | -2.19M | -60.00K | -2.65M | 490.00K | |||
| Interest Paid | 0.00 | 0.00 | 0.00 | 30.00K | 0.00 | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | N/A | 0.00 | |||
| Other non cash items | 3.39M | 4.92M | 2.26M | 22.06M | 700.00K | |||
| OPERATING CASH FLOW | -6.77M | -11.87M | -20.39M | -18.86M | -7.93M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -20.00K | -230.00K | 0.00 | -10.00K | N/A | |||
| Other Investing Activity | N/A | N/A | 0.00 | 970.00K | N/A | |||
| INVESTING CASH FLOW | -20.00K | -230.00K | 0.00 | 960.00K | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 0.00 | N/A | |||
| Stock Issued/Repurchased | 2.58M | 1.86M | 21.64M | 26.08M | 6.63M | |||
| Dividend Paid | -14.00K | -10.00K | -10.00K | -10.00K | -10.00K | |||
| Other Financing Activity | N/A | N/A | 0.00 | -30.00K | -30.00K | |||
| FINANCING CASH FLOW | 2.57M | 1.85M | 21.64M | 26.04M | 6.60M | |||
| CHANGE IN CASH | -4.23M | -10.25M | 1.25M | 8.14M | -1.33M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -6.77M | -11.87M | -20.39M | -18.86M | -7.93M | |||
| Capital Expenditure | -20.00K | -230.00K | 0.00 | -10.00K | N/A | |||
| FREE CASH FLOW | -6.79M | -12.10M | -20.39M | -18.87M | -7.93M | |||
All data in USD